|
Tuesday, December 11, 2007
The Association of the British Pharmaceutical Industry (ABPI) said today that it would be studying the Office of Fair
Trading’s market study into new and proposed medicine distribution arrangements in close detail.
The choice of distribution arrangements by companies is a matter for their commercial judgement, providing that patient
safety, supply chain security, speed of service to pharmacists and general efficiency are maintained.
The ABPI added that the pharmaceutical industry is already working with the UK Government on how medicines can be delivered
to the NHS with the maximum efficiency. The OFT recommendations will be considered in parallel with these discussions.
For further information, please contact:
Crispin Slee 020 7747 1410 (office)
Roz Britton-Elliott 020 7747 1441 (office)
|
